- Home
- INAB vs GELS Comparison
INAB vs GELS Comparison
Compare INAB & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- GELS
- Stock Information
- Founded
- INAB 2016
- GELS 2018
- Country
- INAB United States
- GELS Australia
- Employees
- INAB N/A
- GELS N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- GELS
- Sector
- INAB Health Care
- GELS
- Exchange
- INAB Nasdaq
- GELS NYSE
- Market Cap
- INAB 14.5M
- GELS 15.9M
- IPO Year
- INAB 2021
- GELS 2024
- Fundamental
- Price
- INAB $4.17
- GELS $1.69
- Analyst Decision
- INAB Strong Buy
- GELS
- Analyst Count
- INAB 2
- GELS 0
- Target Price
- INAB $3.60
- GELS N/A
- AVG Volume (30 Days)
- INAB 7.9M
- GELS 85.2K
- Earning Date
- INAB 05-07-2025
- GELS 02-15-2025
- Dividend Yield
- INAB N/A
- GELS N/A
- EPS Growth
- INAB N/A
- GELS N/A
- EPS
- INAB N/A
- GELS N/A
- Revenue
- INAB N/A
- GELS $95,618.00
- Revenue This Year
- INAB N/A
- GELS N/A
- Revenue Next Year
- INAB N/A
- GELS N/A
- P/E Ratio
- INAB N/A
- GELS N/A
- Revenue Growth
- INAB N/A
- GELS N/A
- 52 Week Low
- INAB $0.10
- GELS $0.77
- 52 Week High
- INAB $4.17
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- INAB 98.72
- GELS N/A
- Support Level
- INAB $0.10
- GELS N/A
- Resistance Level
- INAB $0.19
- GELS N/A
- Average True Range (ATR)
- INAB 0.11
- GELS 0.00
- MACD
- INAB 0.26
- GELS 0.00
- Stochastic Oscillator
- INAB 100.00
- GELS 0.00
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.